Envas Injection 1 ml

Envas Injection 1 ml is an anti-hypertensive medicine primarily used in the treatment of Hypertension. It is used when the oral treatment is not effective. Hypertension (high blood pressure) is a serious condition in which the force exerted by the blood against the artery walls becomes high, and this hardens the heart to pump blood.

Envas Injection 1 ml contains Enalaprilat, which belongs to the class of Angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing the production of certain substances responsible for increased blood pressure.

Envas Injection 1 ml may cause certain common side effects such as cough, dizziness, headache, nausea, light-headedness, difficulty breathing, vomiting, confusion, sore throat, chest pain, abdominal pain, diarrhoea, decreased blood pressure, nervousness, injection site reactions, and hoarseness. These side effects do not require medical attention and usually resolve after some time. Envas Injection 1 ml will be administered by a trained healthcare professional. Do not self-administer.

Avoid receiving Envas Injection 1 ml and inform your doctor if you are allergic to it. Envas Injection 1 ml is contraindicated in patients with angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and hereditary or idiopathic angioedema. This medicine should be used with caution if you have/had any conditions such as congestive heart failure, liver or kidney disease, and peripheral oedema (swelling of hands/legs). It is not recommended to take this medicine during pregnancy and breastfeeding.

Envas Injection 1 ml contains Enalaprilat, which belongs to the Angiotensin-converting enzyme (ACE) inhibitors class. It works by reducing the production of certain substances that cause an increase in blood pressure. It allows the blood to flow more smoothly and makes the heart more efficient at pumping blood throughout the body. Envas Injection 1 ml helps reduce high BP and the risk of heart attack, stroke and angina (chest pain).

Avoid receiving Envas Injection 1 ml and inform your doctor if an allergic reaction occurs. Envas Injection 1 ml is contraindicated in patients with angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and hereditary or idiopathic angioedema. Envas Injection 1 ml is not recommended for use in children as the safety and efficacy are not established. On rare occasions, ACE inhibitors have been linked to a syndrome that begins with cholestatic jaundice, advances to fulminant hepatic necrosis, and occasionally results in death. When jaundice or significant elevations in hepatic enzymes occur in patients taking ACE inhibitors, the medication should be stopped, and appropriate medical attention should be given. Before receiving Envas Injection 1 ml, caution should be exercised in patients with congestive heart failure, liver disease, kidney disease, hyperkalaemia, angioedema, cough, and peripheral oedema (swelling of hands/legs). In some patients, this medicine may cause head and neck angioedema, severe anaphylactic reactions, hypotension, hepatic failure, and neutropenia. Hence, inform your doctor about your complete medication and medical history. Avoid consumption of alcohol during the treatment. If you are pregnant or breastfeeding, inform your doctor beforehand.

• Sudden withdrawal may worsen angina (chest pain). However, if you experience chest pain, consult your doctor immediately.
• Frequent monitoring of blood pressure is important while receiving this medicine.
• Abnormal liver and kidney tests must be reported to the doctor.
• Your doctor may suggest a blood test for serum electrolytes (sodium, potassium), and a CBC to check for the occurrence of hyponatremia and hypokalaemia.